Davidson Michael H.
Chief Executive Officer at NAMS
- Sold, on record
- $25.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 2, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NAMSNewAmsterdam Pharma Co N.V.Chief Executive Officer
Sales by reason
2
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NAMSNo planMar 26, 2025 2025
Sold 12,258 shares
Davidson Michael H., Chief Executive Officer
No 10b5-1 planSold 3% of holdings390,441 shares leftFirst sale on recordFiling
- 2 Form 4 sale NAMSRoutineJan 7, 2026 +287 days
Sold 11,582 shares
Davidson Michael H., Chief Executive Officer
10b5-1 planSold 3% of holdings378,859 shares leftFiling
- 3 Form 4 sale NAMSRoutineFeb 26, 2026 +50 days
Sold 306,293 shares at $34.53 ($10.6M)
Davidson Michael H., Chief Executive Officer
10b5-1 planSold 63.8% of holdings ($16.6M position)174,144 shares leftFiling
- 4 Form 4 sale NAMSUnusualMar 2, 2026 +4 days
Sold 443,707 shares at $33.25 ($14.8M)
Davidson Michael H., Chief Executive Officer
No 10b5-1 planSold 71.8% of holdings ($20.5M position)174,144 shares left36.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 2, 2026 | NAMS | Chief Executive Officer | Form 4 sale | 443,707 | $14.8M | 71.8% | Unusual | SEC |
| Feb 26, 2026 | Feb 26, 2026 | NAMS | Chief Executive Officer | Form 4 sale | 306,293 | $10.6M | 63.8% | Routine | SEC |
| Jan 7, 2026 | Jan 9, 2026 | NAMS | Chief Executive Officer | Form 4 sale | 11,582 | 3.0% | Routine | SEC | |
| Mar 26, 2025 | Mar 28, 2025 | NAMS | Chief Executive Officer | Form 4 sale | 12,258 | 3.0% | No plan | SEC |